RxDoctor Payments Data

Lesley Vincent

Family · Meridian, MSNPI 1831333871

Payments from drug & device makers

$4,569in general payments, 2019–2025

Across 174 payments — averaging $26.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Spinal Simplicity, LLC$449
  • Novo Nordisk$363
  • AbbVie$322
  • Boston Scientific$281
  • AstraZeneca$223
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,569 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$167,923
Medicare patients
285
Services billed
3,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen979$19,244
Nurtec OdtRimegepant Sulfate14$18,554
MovantikNaloxegol Oxalate28$16,637
OxycontinOxycodone Hcl20$12,740
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen398$12,541
BelbucaBuprenorphine Hcl13$11,749
SavellaMilnacipran Hcl15$10,874
Oxymorphone Hcl ErOxymorphone Hcl12$8,340
Gabapentin681$6,317
Morphine Sulfate ErMorphine Sulfate140$5,910
Pregabalin355$5,284
Fentanyl33$4,552
Lidocaine38$4,033
Oxycodone Hcl154$3,811
Tizanidine Hcl97$3,645

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$93$18,55414 claims
Collegium Pharmaceutical, Inc.Belbuca$85$11,74913 claims
AbbVieSavella$322$10,87415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.

Other family in Meridian

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →